May 14, 2014 / 11:25 AM / 3 years ago

Isis Pharma's diabetes drug succeeds in mid-stage study

May 14 (Reuters) - Isis Pharmaceuticals Inc said its experimental type 2 diabetes drug reduced blood-sugar levels in patients in a mid-stage study.

The trial was testing two doses of the drug in 75 patients with type 2 diabetes with uncontrolled blood sugar despite standard treatment, the drugmaker said on Wednesday. (Reporting by Natalie Grover in Bangalore; Editing by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below